THE LONG NIGHT OF RESEARCH     Join us on Friday, April 24., 5-11 pm   35 stations at two venues on campus will be waiting for you and your family & friends at the Long Night of Research. The full program is available here: Lange Nacht der Forschung @ Vienna BioCenter  You can find the stations at Dr Bohr Gasse 3 (in and around Vienna Open Lab) and at Djerassiplatz 1 (in the University Biology Building (UBB). The venues are only minutes apart and will offer a diverse program. Many of the scientists speak English (and other languages!) in addition to German and the event is aimed at all age groups.  GMI & IMBA will be part of the ÖAW venue Campus Akademie. Program available here. Learn more about Lange Nacht der Forschung on their website. Spread the word and see you there!        

FEBS April News

Thursday, 16 April 2026 08:24
    Upcoming key dates A. Castellani PhD Meeting | Application deadline 15 April 2026 PROBio-LatAm Fellowships | Application deadline 19 April 2026 FEBS Congress 2026 | Late-breaking abstract deadline 20 April 2026 FEBS | EMBO Women in Science Award | 2027 Nomination deadline 15 May 2026 FEBS Education and Training Supported Society Events | Application deadline 15 June 2026 FEBS Press | FEBS Letters cover contest 31 August 2026 FEBS Advanced Courses | 2027 Call for applications  1 September 2026 FEBS announcements Israel Pecht Award 2026 Prof. Francesco Bonomi (University of Milan, Italy) has been named the recipient of the 2026 Israel Pecht Award, in recognition of his outstanding contributions to the biomolecular sciences community and his long-standing commitment to FEBS and its Constituent Societies. This award honours individuals whose dedication, leadership and service have significantly strengthened the FEBS network and supported the development of the scientific community. ???? The award…
Need for Speed: How Europe Can Compete in the New Era Globally, innovators are finding the need for speed as the driver for investment, partnering and success: speed to the clinic, speed to early human data, and speed to de-risk assets. The question for European biotechs is what's their best strategy to compete in this arena, facing new momentum from Asia, and an unpredictable landscape in the U.S. As always, the science in Europe is there. There are more experienced operators than ever before. And after four long years, investor sentiment, finally, is turning. In its 26th edition, Bio€quity Europe travels to Central and Eastern Europe for the first time to explore opportunities in the region, and to debate how European biotech can accelerate to compete — and lead — in today's world. Register here.  

Page 1 of 106